Category: Regulations
-
Laser-Immunotherapy Now in Cancer Clinical Trial
A new type of cancer treatment that precisely attacks tumors with synthetic antibodies activated by laser beams is being tested in an early-stage clinical trial.
-
Antibody Leads to Sharp Triglyceride, Cholesterol Drop
An experimental synthetic antibody was shown in a clinical trial to markedly reduce triglycerides and the types of cholesterol that contribute to heart disease.
-
Long-Acting Opioid Abuse Therapy Shown Working in Trial
An experimental long-acting drug was shown at least as effective, and in some cases superior, to the current standard of care for opioid use disorder.
-
Seedless Fruit Varieties Seen As Food Security Boost
A review of studies evaluating techniques for producing seedless fruit concludes these techniques can contribute to higher yields that help ensure the security of food supplies.
-
Florida Voters Give Split Decision on GM Mosquitoes [Updated]
Voters in the Florida Keys yesterday returned a split decision on non-binding ballot questions about testing genetically modified mosquitoes to stop the Zika virus.
-
Zika Vaccine Clinical Trial Underway
The first of a series of clinical trials testing inactivated Zika particles as a vaccine to protect against the live Zika virus is recruiting participants.
-
Safety, Effects Shown in Drug Clearing Alzheimer’s Peptides
An experimental drug that clears peptides associated with Alzheimer’s disease from the central nervous system was also shown to be safe for patients in an early clinical trial.
-
Preventive Drugs Offer No Benefit for Children’s Migraine
A clinical trial testing drugs for depression and seizures, but sometimes prescribed to prevent migraines, shows the drugs to be no better than a placebo in preventing migraines among children.
-
Skin Patch Shown to Increase Peanut Tolerance in Children
A skin patch worn by children with peanut allergies was shown in a clinical trial to increase the wearers’ tolerance for peanuts by 10 times after 1 year.
-
Engineered Mosquito Production Facility Opens
A new industrial lab to produce mosquitoes genetically engineered to prevent the spread of infectious diseases opened in Piracicaba, Brazil.